Literature DB >> 27790924

Pharmacogenomics education and research at the Department of Pharmacy, University of Patras, Greece.

George P Patrinos1,2,3, Theodora Katsila1.   

Abstract

The Pharmacogenomics and Personalized Medicine group belongs to the Laboratory of Molecular Biology and Immunology, Department of Pharmacy and is active since 2009 mainly in the field of pharmacogenomics and personalized medicine. Herein, we describe the research interests, collaborations and accomplishments of the Pharmacogenomics and Personalized Medicine group together with the teaching activities of the group that greatly enhance the pharmacogenomics knowledge of graduate/postgraduate students and healthcare professionals.

Keywords:  economic evaluation; ethics; genome informatics; personalized medicine; pharmacogenomic biomarkers; pharmacogenomics; public health

Year:  2016        PMID: 27790924     DOI: 10.2217/pgs-2016-0142

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  3 in total

1.  Perceptions of students in health and molecular life sciences regarding pharmacogenomics and personalized medicine.

Authors:  Lejla Mahmutovic; Betul Akcesme; Camil Durakovic; Faruk Berat Akcesme; Aida Maric; Muhamed Adilovic; Nour Hamad; Matthias Wjst; Oliver Feeney; Sabina Semiz
Journal:  Hum Genomics       Date:  2018-11-14       Impact factor: 4.639

2.  Development of the pharmacogenomics and genomics literacy framework for pharmacists.

Authors:  Azhar T Rahma; Iffat Elbarazi; Bassam R Ali; George P Patrinos; Luai A Ahmed; Mahanna Elsheik; Fatma Al-Maskari
Journal:  Hum Genomics       Date:  2021-10-16       Impact factor: 4.639

3.  Examining key factors impact on health science students' intentions to adopt genetic and pharmacogenomics testing: a comparative path analysis in two different healthcare settings.

Authors:  Margarita-Ioanna Koufaki; Stavroula Siamoglou; George P Patrinos; Konstantinos Vasileiou
Journal:  Hum Genomics       Date:  2022-03-14       Impact factor: 4.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.